Sensitive ASX Announcement

Acrux's sixth generic dossier accepted by FDA for review

Published: 08/08/22, 09:33am (AEST)2 pages
Acrux Limited
ACR:ASXHealthcare

Recent ACR Announcements

Price Sensitive only